Ajinomoto Bio-Pharma (AJINOMOTO ALTHEA INC.)

In News

PCI Pharma Services completes acquisition of Ajinomoto Althea - Pharmaceutical Technology

Pharmaceutical Technology - Aug 28, 2025

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea - Business Wire

Business Wire - Apr 24, 2025

PCI Pharma Services Completes Ajinomoto Althea Acquisition - Contract Pharma

Contract Pharma - May 05, 2025

PCI's expansion tear rolls on with acquisition of fill-finish CDMO Ajinomoto Althea - Fierce Pharma

Fierce Pharma - Apr 28, 2025

Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry - PR Newswire

PR Newswire - Oct 02, 2018

Ajinomoto will lay off 71 staffers in California to streamline CDMO business following $620M Forge Biologics buy - Fierce Pharma

Fierce Pharma - Aug 12, 2024

Ajinomoto Althea Launches New Facility - Contract Pharma

Contract Pharma - Aug 29, 2018

Ajinomoto Bio-Pharma buys Indian API plant from JV partner - Fierce Pharma

Fierce Pharma - Aug 29, 2019

Japan's Ajinomoto Bio-Pharma Services takes control of GeneDesign - Fierce Pharma

Fierce Pharma - Apr 15, 2019

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment